Utilization of site-specific recombination for generating therapeutic protein producing cell lines.
Campbell
Margie
M
Pharmaceutical Development, Gene Expression, Centocor R&D Inc., Radnor, PA, USA. MCampb15@its.jnj.com
Corisdeo
Susanne
S
McGee
Clair
C
Kraichely
Denny
D
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000235:genetics; D001287:Attachment Sites, Microbiological; D016466:CHO Cells; D003001:Cloning, Molecular / Q000379:methods*; D006224:Cricetinae; D003412:Cricetulus; D005822:Genetic Vectors / Q000235:genetics; D010957:Plasmids / Q000235:genetics; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000235:genetics*; D045522:Recombinases / Q000378:metabolism; D011995:Recombination, Genetic
D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D045522:Recombinases